Patient P-02417
Therapy response
Declining
Tolerance
Favorable
GI state
Favorable
Inflammatory state
Improving
Nutritional resilience
Favorable
Discontinuation risk
18%
Trajectory
Baseline → today → 30-day prediction · hover a day for signals and eventssolid = observed · dashed = predicted
- Day 0 META-24 started — Baseline state S18
- Day 13 Trajectory diverged from prediction — Observed response fell below the model's expected path.
- Day 22 DT-01 recommended — Dosing / Timing Recommendation DT-01
- Day 23 Patient accepted — Started DT-01 in the companion
- Day 28 No meaningful change — Dosing / Timing Recommendation DT-01
What changed?
Trajectory began diverging from predicted response on Day 13.
Primary contributors, last 14 days
- Inflammatory activity-5
- Toxicity-4
- GI instability+3
- Nutritional resilience-2
- Treatment adherence+2
What helped?
- Dosing / Timing Recommendation DT-01Day 22Result: no meaningful change
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients.
Biological layers
Which pathways look influenced, and by which layer of this person's biology.
Pathways under pressure
- Mucosal barrier integrity ↓40
- MicrobiomeAkkermansia low → thinner mucus layer
- WearableSleep 4.9 h, below personal baseline
- Butyrate / short-chain fatty acid production ↓25
- MicrobiomeF. prausnitzii depleted
- Autonomic recovery ↑20
- WearableShort sleep window
- Inflammatory signalling ↓15
- WearableHRV 35 ms, trending down
DNA
Fictional pharmacogenomic panel
- CYP2D6 Intermediate metabolizerExpected exposure
- MTHFR C677TReduced folate turnover
Microbiome
Shannon diversity 1.9 · butyrate capacity 48/100
- Akkermansia muciniphilaLow
- Faecalibacterium prausnitziiLow
- Bacteroides fragilisNormal
- Bifidobacterium longumNormal
- EnterobacteriaceaeHigh
Wearable, last 14 days
daily evolution fed into the runtime
- HRV
- 31 ms
- Sleep
- 5.8 h
- Steps
- 4,486
- Resting HR
- 67 bpm
Daily log: GI score 25, nutritional resilience 65, adherence 91.
What this patient sees in NostraAI
The content that steers the trajectory: what to eat, what to do, what to take.
What to eat
- Keep meals regular; three to four moderate portions spaced through the day
- Include a cooked vegetable portion with each main meal
- Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
- Eat slowly and stop at comfortable fullness — smaller volume, more often
What to do
- Log the daily check-in; one line is enough
- Keep the current walking rhythm
- Protect a 7.5-hour sleep window; screens off 30 minutes before
- Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
- Take the dose at the same time relative to your evening meal
- No additional supplements this week
- Fictional demo item: continue vitamin D as before
284 biologically similar trajectories
Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.
| Patient | Similarity | Baseline | Intervention | Outcome | Response today |
|---|---|---|---|---|---|
| P-02639 | 51% | S08 | — | — | 58 |
| P-02126 | 50% | S16 | DT-01 | improved | 59 |
| P-02223 | 50% | S20 | HY-01 | improved | 49 |
| P-02382 | 50% | S18 | — | — | 59 |
| P-02200 | 49% | S13 | — | — | 47 |
| P-02033 | 47% | S06 | GI-04 | improved | 51 |
| P-02037 | 47% | S04 | GI-04 | improved | 53 |
| P-02305 | 47% | S20 | — | — | 46 |
| P-02414 | 47% | S13 | HY-01 | improved | 58 |
| P-02513 | 47% | S16 | GI-04 | no change | 46 |
| P-02058 | 46% | S05 | GI-04 | no change | 48 |
| P-02355 | 46% | S09 | GI-04 | improved | 55 |